Wyeth - Database of Clinical Trials by Pharmaceutical Companies

All Categories Pharma Companies » Wyeth

Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects

Condition: Intestinal Obstruction
Interventions: Drug: Loperamide; Drug: Loperamide placebo; Drug: Methylnaltrexone placebo; Drug: Methylnaltrexone 12 mg sc.; Drug: Methylnaltrexone IR capsule; Drug: Methylnaltrexone ER capsule; Device: Colon Transit; Drug: Sulfasalazine
Sponsors: University Medicine Greifswald; University Medicine Greifswald
Completed - verified May 2012
Temsirolimus as Second-line Therapy in HCC

Condition: Unresectable or Metastatic Hepatocellular Carcinoma
Intervention: Drug: Temsirolimus
Sponsors: University of Tennessee Cancer Institute; University of Tennessee Cancer Institute; Wyeth is now a wholly owned subsidiary of Pfizer
Recruiting - verified March 2012
Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children

Conditions: Varicella; Rubella; Measles; Mumps
Interventions: Biological: Priorix Tetra; Biological: Meningitec
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012
Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions

Condition: Healthy
Intervention: Drug: Venlafaxine
Sponsors: Dr. Reddy's Laboratories Limited; Dr. Reddy's Laboratories Limited
Completed - verified January 2012
Evaluation Of The Product Ciclo® 21 Pharmacodynamics (Levonorgestrel + Ethinyl Estradiol), Marketed By União Química Farmacêutica Nacional S / A, Compared To Nordette® Product To The Lab Wyeth Pharmaceutical Industries Ltd.

Conditions: Pregnancy Prevention; Control of Menstrual Irregularities
Interventions: Drug: Ciclo 21 (LNG + EE2); União Química Farmacêutcia Nacional S/A; Drug: Nordette (LNG + EE2); Laboratory Wyeth Pharmaceutical Ltda
Sponsors: L.A.L Clinica Pesquisa e Desenvolvimento Ltda.; L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
Not yet recruiting - verified December 2011
A Trial of JX-594 in Refractory Colorectal Carcinoma

Condition: Colorectal Carcinoma
Intervention: Biological: JX-594
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified November 2011
An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

Condition: Healthy Volunteers - Influenza A and/or B (GSK Biologicals' Influenza Candidate Vaccine GSK2321138A)
Interventions: Biological: Influenza vaccine GSK2321138A; Biological: Havrix Junior; Biological: Wyeth Prevenar; Biological: Sanofi Pasteur Varivax/ProVarivax; Biological: Varilrix
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012
Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months

Condition: Streptococcus Pneumoniae
Intervention:
Sponsors: Health Protection Agency, United Kingdom; Dr. Elizabeth Miller
Recruiting - verified March 2012
Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions

Condition: Healthy
Intervention: Drug: Venlafaxine Hydrochloride Extended-Release Capsules of Torrent Pharmaceuticals Limited
Sponsors: Torrent Pharmaceuticals Limited; Torrent Pharmaceuticals Limited
Completed - verified August 2011
Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions

Condition: Healthy
Intervention: Drug: Venlafaxine Hydrochloride Extended-Release Capsules 150mg (Test formulation, Torrent Pharmaceutical Limited., India)
Sponsors: Torrent Pharmaceuticals Limited; Torrent Pharmaceuticals Limited
Completed - verified August 2011
Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fasting Conditions

Condition: Healthy
Intervention: Drug: Torrent's Pantoprazole Sodium Delayed - Release Tablets
Sponsors: Torrent Pharmaceuticals Limited; Torrent Pharmaceuticals Limited
Completed - verified August 2011
Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fed Conditions

Condition: Healthy
Intervention: Drug: Torrent's Pantoprazole Sodium Delayed - Release Tablets
Sponsors: Torrent Pharmaceuticals Limited; Torrent Pharmaceuticals Limited
Completed - verified August 2011
Repetitive Transcranial Magnetic Stimulation Compared or Associated With Venlafaxine for Depressive Disorder

Condition: Depression
Interventions: Other: active rTMS and active Venlafaxine; Other: active rTMS and sham Venlafaxine; Other: sham rTMS and active Venlafaxine
Sponsors: Xijing Hospital; Xijing Hospital
Recruiting - verified February 2012